Publication Name	World Journal of Dermatology
Manuscript ID	22527
Country	Türkiye

Received	2015-09-01 08:32
Peer-Review Started	2015-09-02 10:51
To Make the First Decision	2015-09-28 12:21
Return for Revision	2015-09-29 09:47
Revised	2015-10-11 15:26
Second Decision	2015-11-30 09:46
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-12-11 16:47
Articles in Press	2015-12-11 16:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-16 19:38
Publish the Manuscript Online	2016-01-29 17:09

ISSN	2218-6190 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Minireviews
Article Title	Treatment of mycosis fungoides, in the era of stem cell transplantation
Manuscript Source	Invited Manuscript
All Author List	Pusem Patir and Filiz Vural
Funding Agency and Grant Number
Corresponding Author	Filiz Vural, MD, Department of Hematology, Ege University Hospital, Kazimdirik district, Bornova, 35100 Izmir, Turkey. fivural@yahoo.com
Key Words	Mycosis fungoides; Sèzary syndrome; Stem cell transplantation
Core Tip	Some cutaneous T-cell lymphoma patients progress to advanced-stage disease or leukaemic stages. To date, there is no cure for those cases. In the last few years, several publications reported durable responses in some patients following allogeneic hematopoietic stem cell transplantation. Our aim is to define outcomes after hematopoietic stem cell transplantation for mycosis fungoides and Sèzary syndrome.
Publish Date	2016-01-29 17:09
Citation	Patir P, Vural F. Treatment of mycosis fungoides, in the era of stem cell transplantation. World J Dermatol 2016; 5(1): 52-56
URL	http://www.wjgnet.com/2218-6190/full/v5/i1/52.htm
DOI	http://dx.doi.org/10.5314/wjd.v5.i1.52

Full Article (PDF)	WJD-5-52.pdf
Full Article (Word)	WJD-5-52.doc
Manuscript File	22527-Review.doc
Answering Reviewers	22527-Answering reviewers.pdf
Audio Core Tip	22527-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	22527-Conflict-of-interest statement.pdf
Copyright License Agreement	22527-Copyright assignment.pdf
Peer-review Report	22527-Peer-review(s).pdf
Scientific Misconduct Check	22527-Scientific misconduct check.pdf
Scientific Editor Work List	22527-Scientific editor work list.pdf